These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 27777911)

  • 41. [Long term follow up of a patient with type I vitamin D-dependent rickets].
    Velásquez-Jones L; Medeiros M; Valverde-Rosas S; Jiménez-Triana C; Del Moral-Espinosa I; Romo-Vázquez JC; Franco-Alvarez I
    Bol Med Hosp Infant Mex; 2015; 72(3):190-194. PubMed ID: 29421501
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Generation of 1,25-dihydroxyvitamin D
    Nishikawa M; Yasuda K; Takamatsu M; Abe K; Nakagawa K; Tsugawa N; Hirota Y; Tanaka K; Yamashita S; Ikushiro S; Suda T; Okano T; Sakaki T
    J Steroid Biochem Mol Biol; 2019 Jan; 185():71-79. PubMed ID: 30031146
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 1α,24(S)(OH)2D2 normalizes bone morphology and serum parathyroid hormone without hypercalcemia in 25-hydroxyvitamin D-1-hydroxylase (CYP27B1)-deficient mice, an animal model of vitamin D deficiency with secondary hyperparathyroidism.
    St-Arnaud R; Arabian A; Yu VW; Akhouayri O; Knutson JC; Strugnell SA
    J Endocrinol Invest; 2008 Aug; 31(8):711-7. PubMed ID: 18852532
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute life-threatening presentation of vitamin D deficiency rickets.
    Chehade H; Girardin E; Rosato L; Cachat F; Cotting J; Perez MH
    J Clin Endocrinol Metab; 2011 Sep; 96(9):2681-3. PubMed ID: 21795457
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inactivating mutations in the 25-hydroxyvitamin D3 1alpha-hydroxylase gene in patients with pseudovitamin D-deficiency rickets.
    Kitanaka S; Takeyama K; Murayama A; Sato T; Okumura K; Nogami M; Hasegawa Y; Niimi H; Yanagisawa J; Tanaka T; Kato S
    N Engl J Med; 1998 Mar; 338(10):653-61. PubMed ID: 9486994
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeted ablation of the 25-hydroxyvitamin D 1alpha -hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction.
    Panda DK; Miao D; Tremblay ML; Sirois J; Farookhi R; Hendy GN; Goltzman D
    Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7498-503. PubMed ID: 11416220
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nongenomic effects of 1α,25-dihydroxyvitamin D
    Hirota Y; Nakagawa K; Mimatsu S; Sawada N; Sakaki T; Kubodera N; Kamao M; Tsugawa N; Suhara Y; Okano T
    Biochem Biophys Res Commun; 2017 Jan; 483(1):359-365. PubMed ID: 28025137
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Presence of a deletion mutation (c.716delA) in the ligand binding domain of the vitamin D receptor in an Indian patient with vitamin D-dependent rickets type II.
    Kanakamani J; Tomar N; Kaushal E; Tandon N; Goswami R
    Calcif Tissue Int; 2010 Jan; 86(1):33-41. PubMed ID: 19921089
    [TBL] [Abstract][Full Text] [Related]  

  • 49. No enzyme activity of 25-hydroxyvitamin D3 1alpha-hydroxylase gene product in pseudovitamin D deficiency rickets, including that with mild clinical manifestation.
    Kitanaka S; Murayama A; Sakaki T; Inouye K; Seino Y; Fukumoto S; Shima M; Yukizane S; Takayanagi M; Niimi H; Takeyama K; Kato S
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4111-7. PubMed ID: 10566658
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rescue of the phenotype of CYP27B1 (1alpha-hydroxylase)-deficient mice.
    Dardenne O; Prud'homme J; Glorieux FH; St-Arnaud R
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):327-30. PubMed ID: 15225794
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular genetics of vitamin D- dependent hereditary rickets.
    Kato S; Yoshizazawa T; Kitanaka S; Murayama A; Takeyama K
    Horm Res; 2002; 57(3-4):73-8. PubMed ID: 12006701
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lifelong deformities in an adult caused by vitamin D‑dependent rickets type 1A: A case report.
    Yi C; Xu J; He J; Zhang X; Zhang X; Huang J
    Exp Ther Med; 2022 Dec; 24(6):762. PubMed ID: 36561972
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cytochrome P450 enzymes in the bioactivation of vitamin D to its hormonal form (review).
    Wikvall K
    Int J Mol Med; 2001 Feb; 7(2):201-9. PubMed ID: 11172626
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genotype and Phenotype Characteristics in 22 Patients with Vitamin D-Dependent Rickets Type I.
    Tahir S; Demirbilek H; Ozbek MN; Baran RT; Tanriverdi S; Hussain K
    Horm Res Paediatr; 2016; 85(5):309-17. PubMed ID: 26982175
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 1,25-dihydroxyvitamin D3 and 1, alpha-hydroxyvitamin D3 in children: biologic and therapeutic effects in nutritional rickets and different types of vitamin D resistance.
    Balsan S; Garabedian M; Sorgniard R; Holick MF; Deluca HF
    Pediatr Res; 1975 Jul; 9(7):586-93. PubMed ID: 169507
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vitamin D-dependent rickets (VDDR) type 1: case series of two siblings with a CYP27B1 mutation and review of the literature.
    Dhull RS; Jain R; Deepthi B; Cheong HI; Saha A; Mehndiratta M; Basu S
    J Bras Nefrol; 2020; 42(4):494-497. PubMed ID: 32926064
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A toddler with severe vitamin D-dependent rickets type 1 A (VDDR1A), hungry bone syndrome, and severe RSV infection: presentation and therapeutic challenges.
    Statha E; Paltoglou G; Doulgeraki A; Vakali E; Vlachopapadopoulou E; Economou S; Sakou II; Soldatou A; Karavanaki K; Fryssira E
    Hormones (Athens); 2024 Jul; ():. PubMed ID: 39034346
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thyroid hormones decrease plasma 1α,25-dihydroxyvitamin D levels through transcriptional repression of the renal 25-hydroxyvitamin D3 1α-hydroxylase gene (CYP27B1).
    Kozai M; Yamamoto H; Ishiguro M; Harada N; Masuda M; Kagawa T; Takei Y; Otani A; Nakahashi O; Ikeda S; Taketani Y; Takeyama K; Kato S; Takeda E
    Endocrinology; 2013 Feb; 154(2):609-22. PubMed ID: 23307792
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Craniofacial and dental characteristics of patients with vitamin-D-dependent rickets type 1A compared to controls and patients with X-linked hypophosphatemia.
    Gjørup H; Beck-Nielsen SS; Haubek D
    Clin Oral Investig; 2018 Mar; 22(2):745-755. PubMed ID: 28608052
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The combined use of intravenous and oral calcium for the treatment of vitamin D dependent rickets type II (VDDRII).
    al-Aqeel A; Ozand P; Sobki S; Sewairi W; Marx S
    Clin Endocrinol (Oxf); 1993 Aug; 39(2):229-37. PubMed ID: 8396512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.